References
- Howland MA. Pharmacokinetic and toxicokinetic principles. Toxicologic Emergencies, LR Goldfrank. 6th ed., Appleton and Lange, UK 2002; 166–185
- Wells KE, Steed DL, Zajko AB, Webster MW. Recognition and treatment of arterial insufficiency from cafergot. J Vasc Surg 1986; 4: 8–15
- Ford M, Delaney K, Erickson T. Ergot alkaloids. Clinical Toxicology, FP Harchelroad, JR, AR Topliff. W.B. Saunders Company, Illinois 2001; 461–466
- Peroutka SJ. Drugs effective in the therapy of migraine. Goodman and Gilman's The Pharmacological Basis of Therapeutics, JG Hardman, LE Limbird. 9th ed., McGraw-Hill, New York 1996; 487–502, editors-in-Chief.
- Bernstein D. The cardiovascular system. Nelson Textbook of Paediatrics. 15th ed., W.B. Saunders Company, Illinois 1996; 20: 1266–1267
- Paraskevopoulos JA, Teasdale DA, Cuschieri RJ. Severe reversible arterial spasm with ergotamine. Br J Clin Pract 1995; 49: 214
- Allonen H, Juvakoski R, Kanto J. Methylergometrine: comparison of plasma concentrations and clinical response of two brands. Int J Clin Pharmacol Biopharm 1978; 16: 310–342
- Bulow PM, Ibraheem JJ, Paalgow G, Tfelt-Hansen P. Comparison of pharmacodynamic effects and plasma level of oral and rectal ergotamine. Cephalgia 1986; 6: 107–111
- Perrin VL. Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clin Pharmacokinet 1985; 10: 334–352
- Donatini B, Le Blaye I, Krupp P. Inadvertent administration of uterotonics to neonates. Lancet 1993; 341: 839–840
- Pandey S, Haines C. Accidental administration of ergometrine to a newborn infant. Br Med J 1982; 285: 693
- Whitfield MF, Salfield SAW. Accidental administration of syntometrine in adult dosage to the newborn. Arch Dis Childhood 1980; 55: 68–72
- Gancia GP, Cattaneo G, Ferrari G, Scevola G. Intossicazione accidentale da metilergometrina maleato. Minerva Pediatr. 1985; 37: 415–417